NEW YORK (GenomeWeb) – Sygnis said today that it has signed a non-exclusive distribution agreement for its TruePrime product family with Ozyme France.

Under the terms of the agreement, Ozyme will be able to promote, market, and sell existing and future TruePrime products to molecular biologists in France.

TruePrime products combine Sygnis' recently discovered DNA primase TthPrimPol and the Phi29 polymerase, and enable the amplification of total genomic DNA from exceedingly small amounts of sample, down to the single-cell level, without requiring synthetic primers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.